MLB, Bayer One A Day donate to Prostate Cancer Foundation for research
NEW YORK Major League Baseball Properties and Bayer HealthCare’s One A Day Multivitamins, the “official multivitamin of Major League Baseball,” on Monday announced a joint contribution of $328,840 to the Prostate Cancer Foundation resulting from the 2008 “One A Day Men’s presents MLB Strikeout Prostate Cancer Challenge.”
An on-field check presentation ceremony took place in Los Angeles prior Monday night’s National League Championship Series Game Four between the Los Angeles Dodgers and Philadelphia Phillies.
MLBP and One A Day teamed up earlier this year on a four-year sponsorship agreement–the first national sports property sponsorship for the One A Day brand–to support the Prostate Cancer Foundation and fund research to find a cure for prostate cancer, a disease one in six men will be diagnosed with during his lifetime. One A Day Men’s is specially formulated to support prostate health. The “One A Day Men’s presents MLB Strikeout Prostate Cancer Challenge” included a $10 donation by One A Day and MLBP to the Prostate Cancer Foundation for every strikeout recorded during the 2008 Championship Season.
Major League Baseball pitchers totaled 32,884 strikeouts during the 2008 regular season, the most ever recorded.
To further support the program, MLBP and One A Day are extending the initiative to include strikeout totals during the postseason, generating an even larger donation in the fight to eradicate prostate cancer.
“Major League Baseball and One A Day recognize the impact prostate cancer has within our communities and around the nation,” stated Tim Brosnan, Major League Baseball executive vice president, business. “Nutrition, diet and a healthy lifestyle are all integral factors in the fight against this deadly disease, and as the postseason progresses, we will continue tallying strikeouts to raise additional funds.”
“The One A Day brand is proud to be able to make this donation to the Prostate Cancer Research Foundation,” added Jay Kolpon, vice president, marketing, Bayer HealthCare. “Through our men’s products, including One A Day Men’s and One A Day Men’s 50+ Advantage, we are helping to support prostate health and are excited to continue working with Major League Baseball to raise awareness of the disease and our ongoing efforts to help people maintain a healthy lifestyle at all ages.”
Throughout the 2008 regular season, One A Day and MLBP ran full page advertisements in Sports Illustrated for the MLB Strikeout Prostate Cancer Challenge that announced strikeout leaders and donation tallies. One A Day and MLBP also ran Strikeout Prostate Cancer Challenge vignettes on This Week in Baseball presented by Aquafina including strikeout footage and donation tallies.
AAP advises doubling previously recommended amount of vitamin D for children
ELK GROVE VILLAGE, Ill. The American Academy of Pediatrics on Monday updated a 2003 recommendation on vitamin D consumption—suggesting that children should consume 400 International Units of vitamin D daily from the time they’re born through the time they become teenagers—doubling the previous recommendation.
“New evidence supports a potential role for vitamin D in maintaining innate immunity and preventing diseases such as diabetes and cancer,” the AAP said. “The new data may eventually refine what constitutes vitamin D sufficiency or deficiency.”
The new amount also suggests children may need to boost their vitamin D consumption through supplements. The Academy suggests vitamin D(3), cholecalciferol, which is sourced from fish, has greater efficacy in raising vitamin D levels than does vitamin D(2), ergocalciferol, which is plant derived, and noted that most fortified milk products and vitamin supplements now contain cholecalciferol.
The Academy also noted that while multivitamins may be appropriate for older children and adolescents, vitamin D-only drops totaling 400 IUs may be mos appropriate for use with infants.
NARAL calls for Ohio pharmacists to broaden availability of, education about Plan B
CLEVELAND NARAL Pro-Choice Ohio last week released a survey of Ohio pharmacies regarding the general availability of the emergency contraceptive Plan B to women over the age of 18, finding that less than 5 percent of those pharmacies surveyed refused to fill the request of a Plan B purchase “because someone on staff had objections to the medication,” but that as many as 30 percent of pharmacies surveyed either did not carry Plan B or were out of stock at the time of the survey.
Further, only 8 percent of respondents could correctly identify the three possible ways that Plan B works to prevent pregnancy, though it was unclear whether those respondents were all pharmacists. “[One-quarter] of pharmacists or pharmacy employees stated that [Plan B] is the same as the ‘abortion pill,’” NARAL reported.
Pharmacy investigators conducted phone surveys across 216 pharmacies and “secret shopper” surveys of 107 randomly selected pharmacies throughout Ohio between Nov. 1, 2007 and Jan. 31, 2008. The phone surveys were conducted by an individual caller, and the “secret shopper” surveys were conducted by teams of two female investigators.
Following release of the survey, NARAL Pro-Choice Ohio Foundation called on more Ohio pharmacies stock the medication; suggested that both pharmacists and pharmacy staff members need more education into the mechanism of action of Plan B; and recommended Ohio consider changing its Medicaid policies so that women covered by Medicaid can get coverage for Plan B as an OTC medicine considering the average retail of Plan B was $43 according to the survey.